Polio paralytic. New Problems: Postpolio Syndrome

被引:9
作者
Esteban, Jesus
机构
[1] Unidad de Esclerosis Lateral Amiotrófica Sección Neuromuscular, Servicio de Neurología, Hospital Universitario
[2] Servicio de Neurología, Hospital Ruber Internacional
来源
REVISTA ESPANOLA DE SALUD PUBLICA | 2013年 / 87卷 / 05期
关键词
Poliovirus; Poliomyelitis; Polio vaccine; oral; Poliovirus vaccine; inactivated; Disease eradication; Postpoliomyelitis syndrome; MANAGEMENT;
D O I
10.4321/S1135-57272013000500010
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In 1875 M Raymond described a progressive muscle wasting and weakness in 3 individuals survivors of childhood acute poliomyelitis. Jean-Martin Charcot suggested that the initial injury should let these guys neurons more sensitive to develop posterior spinal diseases and new weakness was the result of overuse of the affected muscles. In 1979, after the publication of the description given by a 57 year old patient on motor difficulties that developed after suffering of polio in childhood, there was a very significant increase of comments of other individuals with similar symptoms, reaching wedged in the 80s the term of post-polio syndrome. The term is reserved for describing the development of new neurological symptoms, especially for the development of muscle weakness, muscle atrophy and new muscle fatigue not explained by other medical causes, and appear after more than 15 years of infection acute. Is estimated to affect 20 to 85% of individuals with a history of polio in childhood. In 2000 first described the diagnostic criteria. This syndrome determines a change in the functional abilities. Its pathogenesis is unknown, may be associated with aging. It could also be due to an inflammatory persistent or be influenced by genetic factors. There is no effective drug treatment, so I can only recommend symptomatic and moderate muscle training.
引用
收藏
页码:517 / 522
页数:6
相关论文
共 11 条
[1]  
Agencia de evaluacion de tecnologias sanitarias, 2002, INFORME DE SITUACION
[2]  
Bridgens R, 2010, LANCET NEUROL, V10, P213
[3]   THE POSTPOLIO SYNDROME AS AN EVOLVED CLINICAL ENTITY - DEFINITION AND CLINICAL DESCRIPTION [J].
DALAKAS, MC .
POST-POLIO SYNDROME: ADVANCES IN THE PATHOGENESIS AND TREATMENT, 1995, 753 :68-80
[4]   PATHOGENETIC MECHANISMS OF POSTPOLIO SYNDROME - MORPHOLOGICAL, ELECTROPHYSIOLOGICAL, VIROLOGICAL, AND IMMUNOLOGICAL CORRELATIONS [J].
DALAKAS, MC .
POST-POLIO SYNDROME: ADVANCES IN THE PATHOGENESIS AND TREATMENT, 1995, 753 :167-185
[5]   Management of postpolio syndrome [J].
Gonzalez, Henrik ;
Olsson, Tomas ;
Borg, Kristian .
LANCET NEUROLOGY, 2010, 9 (06) :634-642
[6]   A Brief History of Postpolio Syndrome in the United States [J].
Halstead, Lauro S. .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2011, 92 (08) :1344-1349
[7]   Poliomyelitis and the postpolio syndrome [J].
Howard, RS .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7503) :1314-1318
[8]   Characteristics and management of postpolio syndrome [J].
Jubelt, B ;
Agre, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (04) :412-414
[9]   Postpolio syndrome [J].
Nollet, F ;
de Visser, M .
ARCHIVES OF NEUROLOGY, 2004, 61 (07) :1142-1144
[10]  
Raymond M, 1875, GAZETTE MED PARIS, V4, P225